A Parenting & kids forum. ParentingBanter.com

If this is your first visit, be sure to check out the FAQ by clicking the link above. You may have to register before you can post: click the register link above to proceed. To start viewing messages, select the forum that you want to visit from the selection below.

Go Back   Home » ParentingBanter.com forum » misc.kids » Kids Health
Site Map Home Authors List Search Today's Posts Mark Forums Read Web Partners

ADHD Experts Head To Washington - Is the FDA Up To The Task?



 
 
Thread Tools Display Modes
  #1  
Old March 15th 06, 07:53 PM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

http://www.opednews.com/articles/gen...ts_head_to.htm

ADHD Experts Head To Washington - Is the FDA Up To The Task?

Excerpts:

Heavy-hitters from across the country are heading to Washington this month
to debate representatives of the pharmaceutical industry during FDA hearings
on the controversy surrounding the over-prescribing of attention deficit
drugs to children.

The International Center for the Study of Psychiatry and Psychology (ICSPP)
will be represented by five of the leading experts on attention deficit
disorders at the FDA's Pediatric Advisory Committee's meeting on March 22,
to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace
Jackson, MD, and Dr David Stein. These experts combined have authored
hundreds of books, papers and reports on attention deficit disorders.*

And all five have one common goal; to put an end to the drugging for profit
of the nation's most vulnerable citizens and pharma's most lucrative
customer base - innocent children.

"These children become for-profit receptacles for psychiatric drugs," he
says, "which will, undoubtedly alter their bodies and brains."

Studies have determined that ADHD drugs endanger the cardiovascular system
and according to Dr Jackson, "the cardiovascular risks of stimulants are
hardly new."

"As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner
documented the cell changes associated with heart muscle enlargement in a
chronic consumer of Ritalin."

"The connection between stimulants, cardiovascular disability, and death has
long been documented in the medical literature," Dr Jackson notes, "but
physicians and government regulators have refused to acknowledge the hazards
associated with prescriptions."

Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs
are unnecessary and that their benefits outweigh their risks.

"Whether by ignorance or design," Dr Jackson states, "the regulators remain
oblivious to the evidence-based limitations of the prescription pad: at
least 40% of all children fail to tolerate or respond to stimulant therapy;
about twice as many respond at least as well to non-pharmacological
interventions; and, as documented in the National Institute of Mental Health's
most prestigious study to date (the MTA study), the long term outcomes for
medicated children demonstrate diminishing returns over time, persistent
suppression of growth (about 1 cm per year), and artificial behavioral
improvements which dissipate when treatment is withdrawn."

"Not surprisingly," she says, "the world community observes the United
States with alarm for the unjustified chemical exploitation of those who are
different, but not diseased."

"It is hard to imagine a more serious warning flag than growth inhibition,"
he says, "since it affects the overall growth of the body and all its
organs, including the brain."

Its a well documented fact that the pharmaceutical industry funnels money to
front groups, which in turn fund marketing campaigns and come out to do
battle at times like this when drug company profits are threatened and
scrutinized.

On February 15, 2006, Children and Adults with
Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed
front group responsible for pushing ADHD drugs issued a press release
criticizing the FDA Advisory Committee's recommendation last month to add
black box warnings to the labels of stimulant drugs.

The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and
charged the organization with being a vehicle for marketing a controlled
substance to the public in violation of the international statute known as
the Controlled Substances Act of 1971.

Ritalin is classified as a Schedule II medication. In order for a product to
be classified as a Schedule II drug under the Federal Controlled Substances
Act, it must meet three criteria: one, it has to have a high potential for
abuse; two, it has to have a currently accepted medical use in treatment in
the US; and three, it has to show that abuse may lead to severe
psychological or physical dependence.

It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin
removed from the Schedule II class and moved into a less controlled group to
make the drug easier to buy.
DEA told Congress that police were reporting that Ritalin was being stolen,
sold and traded on playgrounds, as well as snorted, injected, and cut much
like any other amphetamine. Although the DEA presented a thorough report,
nothing was done to slow the sale of Ritalin to children.

And nothing changed as far as CHADD's employment status as a major pusher
for Pharma either. For the fiscal year 2002-2003, the group's financial
statements showed it received more than $670,000 from various drug
companies.

In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs
for Children," reporter Kelly Hearn further discussed the ties between CHADD
and the drug companies in an interview with Dr William Pelham, director of
the Center for Children and Families at State University of New York at
Buffalo, a leading ADHD researcher for 30 years, and a former advisory board
member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta.

Over his career, Dr Pelham has written over 250 research papers on ADHD, and
in 2002, he even received a lifetime achievement award from CHADD.

However, he has few good words to say about CHADD, regulatory officials,
medical professionals, or anybody else involved in selling ADHD drugs to
children.

"In recent years," Dr Pelham told Alternet, "I have come to believe that the
individuals who advocate most strongly in favor of medication - both those
from the professional community, including the National Institutes of Mental
Health, and those from advocacy groups, including CHADD - have major and
undisclosed conflicts of interest with the pharmaceutical companies that
deal with ADHD products."

"I believe that parents of ADHD children and the public at large should be
made aware of this situation," he told Ms Hearn.

Representatives of CHADD showed up at the FDA hearings last month and the
group will no doubt be out in full force this month ready to go head to head
against pharma's number one enemy - the advocacy groups opposed to the mass
drugging of children for profit.


  #2  
Old March 16th 06, 01:42 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

Jan Drew wrote:
http://www.opednews.com/articles/gen...ts_head_to.htm

ADHD Experts Head To Washington - Is the FDA Up To The Task?

Excerpts:

Heavy-hitters from across the country are heading to Washington this month
to debate representatives of the pharmaceutical industry during FDA hearings
on the controversy surrounding the over-prescribing of attention deficit
drugs to children.

The International Center for the Study of Psychiatry and Psychology (ICSPP)
will be represented by five of the leading experts on attention deficit
disorders at the FDA's Pediatric Advisory Committee's meeting on March 22,
to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose Ravenel, Dr Grace
Jackson, MD, and Dr David Stein. These experts combined have authored
hundreds of books, papers and reports on attention deficit disorders.*


BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study
in decades. Breggin's colleague quit that group because he could not
stand Breggin's lies. Breggin has been discredited many times in court,
when he was allowed to testify. He has not been allowed to testify many
times. I previously documented this.

Baughman is one of the promotors of the 5 now defunct and dismissed
Ritalin lawsuits. He has never published any research regarding AD/HD.

Ravenel has never published a research study on AD/HD. Does have some on
spanking.

Jackson has no published research papers on AD/HD.

Stein has no published papers on AD/HD/.

Searched PubMed using search string of Last Name, First Initial, AD/HD.

BIG Yawn.



And all five have one common goal; to put an end to the drugging for profit
of the nation's most vulnerable citizens and pharma's most lucrative
customer base - innocent children.


Yes, Ms. Dingle does have a decidedly anti-medication bias.


"These children become for-profit receptacles for psychiatric drugs," he
says, "which will, undoubtedly alter their bodies and brains."

Studies have determined that ADHD drugs endanger the cardiovascular system
and according to Dr Jackson, "the cardiovascular risks of stimulants are
hardly new."

"As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner
documented the cell changes associated with heart muscle enlargement in a
chronic consumer of Ritalin."

"The connection between stimulants, cardiovascular disability, and death has
long been documented in the medical literature," Dr Jackson notes, "but
physicians and government regulators have refused to acknowledge the hazards
associated with prescriptions."

Dr Jackson takes exception with FDA officials who say warnings on ADHD drugs
are unnecessary and that their benefits outweigh their risks.

"Whether by ignorance or design," Dr Jackson states, "the regulators remain
oblivious to the evidence-based limitations of the prescription pad: at
least 40% of all children fail to tolerate or respond to stimulant therapy;
about twice as many respond at least as well to non-pharmacological
interventions; and, as documented in the National Institute of Mental Health's
most prestigious study to date (the MTA study), the long term outcomes for
medicated children demonstrate diminishing returns over time, persistent
suppression of growth (about 1 cm per year), and artificial behavioral
improvements which dissipate when treatment is withdrawn."

"Not surprisingly," she says, "the world community observes the United
States with alarm for the unjustified chemical exploitation of those who are
different, but not diseased."

"It is hard to imagine a more serious warning flag than growth inhibition,"
he says, "since it affects the overall growth of the body and all its
organs, including the brain."

Its a well documented fact that the pharmaceutical industry funnels money to
front groups, which in turn fund marketing campaigns and come out to do
battle at times like this when drug company profits are threatened and
scrutinized.

On February 15, 2006, Children and Adults with
Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma backed
front group responsible for pushing ADHD drugs issued a press release
criticizing the FDA Advisory Committee's recommendation last month to add
black box warnings to the labels of stimulant drugs.

The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and
charged the organization with being a vehicle for marketing a controlled
substance to the public in violation of the international statute known as
the Controlled Substances Act of 1971.

Ritalin is classified as a Schedule II medication. In order for a product to
be classified as a Schedule II drug under the Federal Controlled Substances
Act, it must meet three criteria: one, it has to have a high potential for
abuse; two, it has to have a currently accepted medical use in treatment in
the US; and three, it has to show that abuse may lead to severe
psychological or physical dependence.

It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin
removed from the Schedule II class and moved into a less controlled group to
make the drug easier to buy.
DEA told Congress that police were reporting that Ritalin was being stolen,
sold and traded on playgrounds, as well as snorted, injected, and cut much
like any other amphetamine. Although the DEA presented a thorough report,
nothing was done to slow the sale of Ritalin to children.

And nothing changed as far as CHADD's employment status as a major pusher
for Pharma either. For the fiscal year 2002-2003, the group's financial
statements showed it received more than $670,000 from various drug
companies.

In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD Drugs
for Children," reporter Kelly Hearn further discussed the ties between CHADD
and the drug companies in an interview with Dr William Pelham, director of
the Center for Children and Families at State University of New York at
Buffalo, a leading ADHD researcher for 30 years, and a former advisory board
member of McNeil Pharmaceuticals, which markets the ADHD drug Concerta.

Over his career, Dr Pelham has written over 250 research papers on ADHD, and
in 2002, he even received a lifetime achievement award from CHADD.

However, he has few good words to say about CHADD, regulatory officials,
medical professionals, or anybody else involved in selling ADHD drugs to
children.

"In recent years," Dr Pelham told Alternet, "I have come to believe that the
individuals who advocate most strongly in favor of medication - both those
from the professional community, including the National Institutes of Mental
Health, and those from advocacy groups, including CHADD - have major and
undisclosed conflicts of interest with the pharmaceutical companies that
deal with ADHD products."

"I believe that parents of ADHD children and the public at large should be
made aware of this situation," he told Ms Hearn.

Representatives of CHADD showed up at the FDA hearings last month and the
group will no doubt be out in full force this month ready to go head to head
against pharma's number one enemy - the advocacy groups opposed to the mass
drugging of children for profit.


  #3  
Old March 16th 06, 02:50 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

Twittering One wrote:
You know,
as I have always said, ask the kid.

If the kid hates the meds,
something is wrong.

If the kid feels better on the meds,
feels better about his/her abilities,
something is right.


Agreed. Input from the patient, child or adult, is always important.


I went for 24 years before I ever
took a an ADD-like med (diet pill)
and felt GOOD about my abilities.

And then I went another 18 years
without any medication options.

If I had been offered a choice,
I would have taken the meds.

But that was another decade.

  #4  
Old March 16th 06, 04:05 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?


"Mark Probert" [please excuse Mark Probert hissy fits]
Jan Drew wrote:
http://www.opednews.com/articles/gen...ts_head_to.htm

ADHD Experts Head To Washington - Is the FDA Up To The Task?

Excerpts:

Heavy-hitters from across the country are heading to Washington this
month to debate representatives of the pharmaceutical industry during FDA
hearings on the controversy surrounding the over-prescribing of attention
deficit drugs to children.

The International Center for the Study of Psychiatry and Psychology
(ICSPP) will be represented by five of the leading experts on attention
deficit disorders at the FDA's Pediatric Advisory Committee's meeting on
March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose
Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined
have authored hundreds of books, papers and reports on attention deficit
disorders.*


BWHAHAHAHAHAHA!


[snip]



And all five have one common goal; to put an end to the drugging for
profit of the nation's most vulnerable citizens and pharma's most
lucrative customer base - innocent children.



"These children become for-profit receptacles for psychiatric drugs," he
says, "which will, undoubtedly alter their bodies and brains."

Studies have determined that ADHD drugs endanger the cardiovascular
system and according to Dr Jackson, "the cardiovascular risks of
stimulants are hardly new."

"As early as 1977," she says, "Drs. Vernon Fischer and Hendrick Barner
documented the cell changes associated with heart muscle enlargement in a
chronic consumer of Ritalin."

"The connection between stimulants, cardiovascular disability, and death
has long been documented in the medical literature," Dr Jackson notes,
"but physicians and government regulators have refused to acknowledge the
hazards associated with prescriptions."

Dr Jackson takes exception with FDA officials who say warnings on ADHD
drugs are unnecessary and that their benefits outweigh their risks.

"Whether by ignorance or design," Dr Jackson states, "the regulators
remain oblivious to the evidence-based limitations of the prescription
pad: at least 40% of all children fail to tolerate or respond to
stimulant therapy; about twice as many respond at least as well to
non-pharmacological interventions; and, as documented in the National
Institute of Mental Health's most prestigious study to date (the MTA
study), the long term outcomes for medicated children demonstrate
diminishing returns over time, persistent suppression of growth (about 1
cm per year), and artificial behavioral improvements which dissipate when
treatment is withdrawn."

"Not surprisingly," she says, "the world community observes the United
States with alarm for the unjustified chemical exploitation of those who
are different, but not diseased."

"It is hard to imagine a more serious warning flag than growth
inhibition," he says, "since it affects the overall growth of the body
and all its organs, including the brain."

Its a well documented fact that the pharmaceutical industry funnels money
to front groups, which in turn fund marketing campaigns and come out to
do battle at times like this when drug company profits are threatened and
scrutinized.

On February 15, 2006, Children and Adults with
Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma
backed front group responsible for pushing ADHD drugs issued a press
release criticizing the FDA Advisory Committee's recommendation last
month to add black box warnings to the labels of stimulant drugs.

The INCB discovered CHADD had received over $775,000 from Ciba-Geigy and
charged the organization with being a vehicle for marketing a controlled
substance to the public in violation of the international statute known
as the Controlled Substances Act of 1971.

Ritalin is classified as a Schedule II medication. In order for a product
to be classified as a Schedule II drug under the Federal Controlled
Substances Act, it must meet three criteria: one, it has to have a high
potential for abuse; two, it has to have a currently accepted medical use
in treatment in the US; and three, it has to show that abuse may lead to
severe psychological or physical dependence.

It seems CHADD was lobbying the Drug Enforcement Agency to get Ritalin
removed from the Schedule II class and moved into a less controlled group
to make the drug easier to buy.
DEA told Congress that police were reporting that Ritalin was being
stolen, sold and traded on playgrounds, as well as snorted, injected, and
cut much like any other amphetamine. Although the DEA presented a
thorough report, nothing was done to slow the sale of Ritalin to
children.

And nothing changed as far as CHADD's employment status as a major pusher
for Pharma either. For the fiscal year 2002-2003, the group's financial
statements showed it received more than $670,000 from various drug
companies.

In the November 29, 2004 Alternet article "Drug Companies Pushing ADHD
Drugs for Children," reporter Kelly Hearn further discussed the ties
between CHADD and the drug companies in an interview with Dr William
Pelham, director of the Center for Children and Families at State
University of New York at Buffalo, a leading ADHD researcher for 30
years, and a former advisory board member of McNeil Pharmaceuticals,
which markets the ADHD drug Concerta.

Over his career, Dr Pelham has written over 250 research papers on ADHD,
and in 2002, he even received a lifetime achievement award from CHADD.

However, he has few good words to say about CHADD, regulatory officials,
medical professionals, or anybody else involved in selling ADHD drugs to
children.

"In recent years," Dr Pelham told Alternet, "I have come to believe that
the individuals who advocate most strongly in favor of medication - both
those from the professional community, including the National Institutes
of Mental Health, and those from advocacy groups, including CHADD - have
major and undisclosed conflicts of interest with the pharmaceutical
companies that deal with ADHD products."

"I believe that parents of ADHD children and the public at large should
be made aware of this situation," he told Ms Hearn.

Representatives of CHADD showed up at the FDA hearings last month and the
group will no doubt be out in full force this month ready to go head to
head against pharma's number one enemy - the advocacy groups opposed to
the mass drugging of children for profit.



  #5  
Old March 16th 06, 05:22 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?


Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits]


Another utterly pointless post from Jan, proving only that she can't
rebut anything Mark said.

snip

  #6  
Old March 16th 06, 05:58 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

Twittering One wrote:
You know,
as I have always said, ask the kid.

If the kid hates the meds,
something is wrong.

If the kid feels better on the meds,
feels better about his/her abilities,
something is right.

Are you sure about this?

I never took stimulant medicine when I was a kid.

When I first took it in my mid 30's, I had a genuine identity crisis.


Who is the real me?

... w/o stimulants
... with stimulants

It was very, very confusing.
I was quite concerned about the issue
. ... I continue to revisit the question occasionally.

The understanding of an adult is qualitatively different to that of a
child.
The motivations of adults are different than that of children.

It's all to easy to stand here & now and look back as myself as a child
considering it from an adult's perspective; from the experience of
reality with which I am presently, most familiar.

I.E. I am projecting the 'adult' me onto the 'myself' as a child.
... I don't think that it is the same point of view. In short .. I am
fooling myself.

Frankly, I don't think that any child would choose to take a reality
altering drug ( .. on occasion, perhaps to escape fear, or stress
... but these are abberant situations in some ways )

I suspect the kid ... any kid, .. would prefer most of all to be him
or her 'self'.

Ergo: ... No drug could feel right!

Eh?

Cordially,

RL


I went for 24 years before I ever
took a an ADD-like med (diet pill)
and felt GOOD about my abilities.

And then I went another 18 years
without any medication options.

If I had been offered a choice,
I would have taken the meds.

But that was another decade.


  #7  
Old March 16th 06, 02:59 PM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits]


There was no hissy fit. I explained why this shill for class-action
lawyers has a credibility problem with the so-called "experts". I'll
restore the post with my comments intact, as YOU CANNOT handle the TRUTH.

Jan Drew wrote:

http://www.opednews.com/articles/gen...ts_head_to.htm

ADHD Experts Head To Washington - Is the FDA Up To The Task?

Excerpts:

Heavy-hitters from across the country are heading to Washington this

month to debate representatives of the pharmaceutical industry during
FDA hearings on the controversy surrounding the over-prescribing of
attention deficit drugs to children.

The International Center for the Study of Psychiatry and Psychology

(ICSPP) will be represented by five of the leading experts on attention
deficit disorders at the FDA's Pediatric Advisory Committee's meeting on
March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose
Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts
combined have authored hundreds of books, papers and reports on
attention deficit disorders.*

BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study
in decades. Breggin's colleague quit that group because he could not
stand Breggin's lies. Breggin has been discredited many times in court,
when he was allowed to testify. He has not been allowed to testify many
times. I previously documented this.

Baughman is one of the promotors of the 5 now defunct and dismissed
Ritalin lawsuits. He has never published any research regarding AD/HD.

Ravenel has never published a research study on AD/HD. Does have some on
spanking.

Jackson has no published research papers on AD/HD.

Stein has no published papers on AD/HD/.

Searched PubMed using search string of Last Name, First Initial, AD/HD.

BIG Yawn.



And all five have one common goal; to put an end to the drugging for

profit of the nation's most vulnerable citizens and pharma's most
lucrative customer base - innocent children.

Yes, Ms. Dingle does have a decidedly anti-medication bias.


"These children become for-profit receptacles for psychiatric drugs,"

he says, "which will, undoubtedly alter their bodies and brains."

Studies have determined that ADHD drugs endanger the cardiovascular

system and according to Dr Jackson, "the cardiovascular risks of
stimulants are hardly new."

"As early as 1977," she says, "Drs. Vernon Fischer and Hendrick

Barner documented the cell changes associated with heart muscle
enlargement in a chronic consumer of Ritalin."

"The connection between stimulants, cardiovascular disability, and

death has long been documented in the medical literature," Dr Jackson
notes, "but physicians and government regulators have refused to
acknowledge the hazards associated with prescriptions."

Dr Jackson takes exception with FDA officials who say warnings on

ADHD drugs are unnecessary and that their benefits outweigh their risks.

"Whether by ignorance or design," Dr Jackson states, "the regulators

remain oblivious to the evidence-based limitations of the prescription
pad: at least 40% of all children fail to tolerate or respond to
stimulant therapy; about twice as many respond at least as well to
non-pharmacological interventions; and, as documented in the National
Institute of Mental Health's most prestigious study to date (the MTA
study), the long term outcomes for medicated children demonstrate
diminishing returns over time, persistent suppression of growth (about 1
cm per year), and artificial behavioral improvements which dissipate
when treatment is withdrawn."

"Not surprisingly," she says, "the world community observes the

United States with alarm for the unjustified chemical exploitation of
those who are different, but not diseased."

"It is hard to imagine a more serious warning flag than growth

inhibition," he says, "since it affects the overall growth of the body
and all its organs, including the brain."

Its a well documented fact that the pharmaceutical industry funnels

money to front groups, which in turn fund marketing campaigns and come
out to do battle at times like this when drug company profits are
threatened and scrutinized.

On February 15, 2006, Children and Adults with

Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma
backed front group responsible for pushing ADHD drugs issued a press
release criticizing the FDA Advisory Committee's recommendation last
month to add black box warnings to the labels of stimulant drugs.

The INCB discovered CHADD had received over $775,000 from Ciba-Geigy

and charged the organization with being a vehicle for marketing a
controlled substance to the public in violation of the international
statute known as the Controlled Substances Act of 1971.

Ritalin is classified as a Schedule II medication. In order for a

product to be classified as a Schedule II drug under the Federal
Controlled Substances Act, it must meet three criteria: one, it has to
have a high potential for abuse; two, it has to have a currently
accepted medical use in treatment in the US; and three, it has to show
that abuse may lead to severe psychological or physical dependence.

It seems CHADD was lobbying the Drug Enforcement Agency to get

Ritalin removed from the Schedule II class and moved into a less
controlled group to make the drug easier to buy.
DEA told Congress that police were reporting that Ritalin was being

stolen, sold and traded on playgrounds, as well as snorted, injected,
and cut much like any other amphetamine. Although the DEA presented a
thorough report, nothing was done to slow the sale of Ritalin to children.

And nothing changed as far as CHADD's employment status as a major

pusher for Pharma either. For the fiscal year 2002-2003, the group's
financial statements showed it received more than $670,000 from various
drug companies.

In the November 29, 2004 Alternet article "Drug Companies Pushing

ADHD Drugs for Children," reporter Kelly Hearn further discussed the
ties between CHADD and the drug companies in an interview with Dr
William Pelham, director of the Center for Children and Families at
State University of New York at Buffalo, a leading ADHD researcher for
30 years, and a former advisory board member of McNeil Pharmaceuticals,
which markets the ADHD drug Concerta.

Over his career, Dr Pelham has written over 250 research papers on

ADHD, and in 2002, he even received a lifetime achievement award from CHADD.

However, he has few good words to say about CHADD, regulatory

officials, medical professionals, or anybody else involved in selling
ADHD drugs to children.

"In recent years," Dr Pelham told Alternet, "I have come to believe

that the individuals who advocate most strongly in favor of medication -
both those from the professional community, including the National
Institutes of Mental Health, and those from advocacy groups, including
CHADD - have major and undisclosed conflicts of interest with the
pharmaceutical companies that deal with ADHD products."

"I believe that parents of ADHD children and the public at large

should be made aware of this situation," he told Ms Hearn.

Representatives of CHADD showed up at the FDA hearings last month and

the group will no doubt be out in full force this month ready to go head
to head against pharma's number one enemy - the advocacy groups opposed
to the mass drugging of children for profit.

  #8  
Old March 16th 06, 02:59 PM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?

cathyb wrote:
Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits]


Another utterly pointless post from Jan, proving only that she can't
rebut anything Mark said.


True. Especially about Breggin.
  #9  
Old March 17th 06, 02:07 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?


"Mark Probert" wrote:
Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits]


There was no hissy fit. I explained why this shill for class-action
lawyers has a credibility problem with the so-called "experts". I'll
restore the post with my comments intact, as YOU CANNOT handle the TRUTH.

Jan Drew wrote:

http://www.opednews.com/articles/gen...ts_head_to.htm

ADHD Experts Head To Washington - Is the FDA Up To The Task?

Excerpts:

Heavy-hitters from across the country are heading to Washington this

month to debate representatives of the pharmaceutical industry during FDA
hearings on the controversy surrounding the over-prescribing of attention
deficit drugs to children.

The International Center for the Study of Psychiatry and Psychology

(ICSPP) will be represented by five of the leading experts on attention
deficit disorders at the FDA's Pediatric Advisory Committee's meeting on
March 22, to include Dr Fred Baughman, Dr Peter Breggin, Dr S DuBose
Ravenel, Dr Grace Jackson, MD, and Dr David Stein. These experts combined
have authored hundreds of books, papers and reports on attention deficit
disorders.*

BWHAHAHAHAHAHA! Breggin and Bughman have not conducted a research study in
decades. Breggin's colleague quit that group because he could not stand
Breggin's lies. Breggin has been discredited many times in court, when he
was allowed to testify. He has not been allowed to testify many times. I
previously documented this.

Baughman is one of the promotors of the 5 now defunct and dismissed
Ritalin lawsuits. He has never published any research regarding AD/HD.

Ravenel has never published a research study on AD/HD. Does have some on
spanking.

Jackson has no published research papers on AD/HD.

Stein has no published papers on AD/HD/.

Searched PubMed using search string of Last Name, First Initial, AD/HD.

BIG Yawn.


Mark can NOT post and tell the truth!

FACT: Nothing was mentioned about anyone doing a study.

FACT: Research Papers weren't mentioned.


FACT: Dr Beggin IS a expert.

FACT r. David Stein has several books.

FACT: Dr. Baughman has authored scientific articles that have appeared in
leading national and international medical journals.


FACT: The Under Reported Story : ADHD, Stimulants, and the FDA.
By Grace E. Jackson MD
February 18, 2006

FACT: Dr S DuBose Ravenel

http://www.audiblox2000.com/rev00.htm

http://pediatrics.aappublications.or...ters/115/1/e97




And all five have one common goal; to put an end to the drugging for

profit of the nation's most vulnerable citizens and pharma's most
lucrative customer base - innocent children.

Yes, Ms. Dingle does have a decidedly anti-medication bias.


FACT: You are a name caller, a EXPOSED LIAR , as just proven, A G A I
N!!!!!!

AND

A HARASSER.

FACT: (Evelyn Pringle is a columnist for Independent Media TV and an
investigative journalist focused on exposing government corruption)



"These children become for-profit receptacles for psychiatric drugs,"

he says, "which will, undoubtedly alter their bodies and brains."

Studies have determined that ADHD drugs endanger the cardiovascular

system and according to Dr Jackson, "the cardiovascular risks of
stimulants are hardly new."

"As early as 1977," she says, "Drs. Vernon Fischer and Hendrick

Barner documented the cell changes associated with heart muscle
enlargement in a chronic consumer of Ritalin."

"The connection between stimulants, cardiovascular disability, and

death has long been documented in the medical literature," Dr Jackson
notes, "but physicians and government regulators have refused to
acknowledge the hazards associated with prescriptions."

Dr Jackson takes exception with FDA officials who say warnings on

ADHD drugs are unnecessary and that their benefits outweigh their risks.

"Whether by ignorance or design," Dr Jackson states, "the regulators

remain oblivious to the evidence-based limitations of the prescription
pad: at least 40% of all children fail to tolerate or respond to stimulant
therapy; about twice as many respond at least as well to
non-pharmacological interventions; and, as documented in the National
Institute of Mental Health's most prestigious study to date (the MTA
study), the long term outcomes for medicated children demonstrate
diminishing returns over time, persistent suppression of growth (about 1
cm per year), and artificial behavioral improvements which dissipate when
treatment is withdrawn."

"Not surprisingly," she says, "the world community observes the

United States with alarm for the unjustified chemical exploitation of
those who are different, but not diseased."

"It is hard to imagine a more serious warning flag than growth

inhibition," he says, "since it affects the overall growth of the body and
all its organs, including the brain."

Its a well documented fact that the pharmaceutical industry funnels

money to front groups, which in turn fund marketing campaigns and come out
to do battle at times like this when drug company profits are threatened
and scrutinized.

On February 15, 2006, Children and Adults with

Attention-Deficit/Hyperactivity Disorder (CHADD), the leading Pharma
backed front group responsible for pushing ADHD drugs issued a press
release criticizing the FDA Advisory Committee's recommendation last month
to add black box warnings to the labels of stimulant drugs.

The INCB discovered CHADD had received over $775,000 from Ciba-Geigy

and charged the organization with being a vehicle for marketing a
controlled substance to the public in violation of the international
statute known as the Controlled Substances Act of 1971.

Ritalin is classified as a Schedule II medication. In order for a

product to be classified as a Schedule II drug under the Federal
Controlled Substances Act, it must meet three criteria: one, it has to
have a high potential for abuse; two, it has to have a currently accepted
medical use in treatment in the US; and three, it has to show that abuse
may lead to severe psychological or physical dependence.

It seems CHADD was lobbying the Drug Enforcement Agency to get

Ritalin removed from the Schedule II class and moved into a less
controlled group to make the drug easier to buy.
DEA told Congress that police were reporting that Ritalin was being

stolen, sold and traded on playgrounds, as well as snorted, injected, and
cut much like any other amphetamine. Although the DEA presented a thorough
report, nothing was done to slow the sale of Ritalin to children.

And nothing changed as far as CHADD's employment status as a major

pusher for Pharma either. For the fiscal year 2002-2003, the group's
financial statements showed it received more than $670,000 from various
drug companies.

In the November 29, 2004 Alternet article "Drug Companies Pushing

ADHD Drugs for Children," reporter Kelly Hearn further discussed the ties
between CHADD and the drug companies in an interview with Dr William
Pelham, director of the Center for Children and Families at State
University of New York at Buffalo, a leading ADHD researcher for 30 years,
and a former advisory board member of McNeil Pharmaceuticals, which
markets the ADHD drug Concerta.

Over his career, Dr Pelham has written over 250 research papers on

ADHD, and in 2002, he even received a lifetime achievement award from
CHADD.

However, he has few good words to say about CHADD, regulatory

officials, medical professionals, or anybody else involved in selling ADHD
drugs to children.

"In recent years," Dr Pelham told Alternet, "I have come to believe

that the individuals who advocate most strongly in favor of medication -
both those from the professional community, including the National
Institutes of Mental Health, and those from advocacy groups, including
CHADD - have major and undisclosed conflicts of interest with the
pharmaceutical companies that deal with ADHD products."

"I believe that parents of ADHD children and the public at large

should be made aware of this situation," he told Ms Hearn.

Representatives of CHADD showed up at the FDA hearings last month and

the group will no doubt be out in full force this month ready to go head
to head against pharma's number one enemy - the advocacy groups opposed to
the mass drugging of children for profit.



  #10  
Old March 17th 06, 02:09 AM posted to misc.health.alternative,alt.support.attn-deficit,misc.kids.health,talk.politics.medicine
external usenet poster
 
Posts: n/a
Default ADHD Experts Head To Washington - Is the FDA Up To The Task?


"Mark Probert" wrote
cathyb wrote:
Jan Drew wrote:
"Mark Probert" [please excuse Mark Probert hissy fits]


Another utterly pointless post from Jan, proving only that she can't
rebut anything Mark said.


True. Especially about Breggin.


Bless.


 




Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

vB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Is ADHD a Real Disease? JanD Kids Health 46 March 4th 06 09:42 PM
BRAVO! Congress Bars Schools From Requiring ADHD Drug Treatment Ilena Rose Kids Health 9 November 18th 05 11:09 PM
CNN: FDA panel wants clearer ADHD labels Ilena Rose Kids Health 51 July 7th 05 09:42 PM
A Few Simple Truths About ADHD and Stimulant Drugs Psi Kids Health 28 April 23rd 04 02:40 PM
Chiro care of baby penises (also: Dr. Poland never sued Dr. Gastaldo) Todd Gastaldo Pregnancy 6 April 7th 04 04:58 PM


All times are GMT +1. The time now is 11:44 PM.


Powered by vBulletin® Version 3.6.4
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.
Copyright ©2004-2024 ParentingBanter.com.
The comments are property of their posters.